Cargando…
Health Economic Assessment of Optimal Biological Treatment for Moderate-to-Severe Psoriasis
BACKGROUND: There is limited guidance on which biologic therapies should be prioritised for the treatment of moderate-to-severe psoriasis, amongst the many available options. New mode-of-action biologics, as well as recently available biosimilars for existing biologics, continue to be developed maki...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556196/ https://www.ncbi.nlm.nih.gov/pubmed/34655022 http://dx.doi.org/10.1007/s40261-021-01089-4 |